Cardiac involvement in Crohn's disease: Echocardiographic study

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 1, 2007, Pages 18-22

  Bragagni, Gianpaolo ^a   Brogna, Raffaele ^a   Franceschetti, Paola ^a   Zoli, Giorgio ^a  

^a SS Annunziata Hospital   (Italy)

Author keywords

Cardiac involvement; Crohn's disease; Echocardiography; Mitral valve prolapse; Pericardial effusion

Indexed keywords

ADULT; AORTA VALVE REGURGITATION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; MORPHOLOGY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRANSTHORACIC ECHOCARDIOGRAPHY; TRICUSPID VALVE REGURGITATION;

EID: 33845641776     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04384.x     Document Type: Article

References (64)

1. Weiss A, Mayer L. Extraintestinal manifestations of inflammatory bowel disease. In: Allan NA, Rhodes JM, Hanauer SB, Keighley MRB, Alexander-Williams J, Fazio VW, eds. Inflammatory Bowel Disease, 3rd edn. New York: Churchill Livingstone, 1999; 623-31.
2. Ward RL. Endocarditis complicating ulcerative colitis. Gastroenterology 1977; 73: 1189-90.
3. Burdick S, Tresch DD, Komokowski RA. Cardiac valvular dysfunction associated with Crohn's disease in the absence of ankylosing spondylitis. Am. Heart J. 1989; 118: 174-6.
4. Nash CL, Panaccione R, Sutherland LR et al. Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept: a tumour necrosis factor-alpha antagonist. Can. J. Gastroenterol. 2001; 15: 607-11.
5. Hyttinen L, Kaipiainen-Seppanen O, Halinen M. Recurrent myopericarditis in association with Crohn's disease. J. Intern. Med. 2003; 253: 386-8.
6. Dubowitz M, Gorard DA. Cardiomyopathy and pericardial tamponade in ulcerative colitis. Eur. J. Gastroenterol. Hepatol. 2001; 13: 1255-8.
7. Sarrouj BJ, Zampino DJ, Cilursu AM. Pericarditis as the initial manifestation of inflammatory bowel disease. Chest 1994; 106: 1911-12.
8. Pang JA. Acute pericarditis. An unusual presentation of an exacerbation of ulcerative colitis. Med. J. Aust. 1985; 143: 356.
9. Ballinger A, Farthing MJ. Ulcerative colitis complicated by Wenckebach atrioventricular block. Gut 1992; 33: 1427-9.
10. Best WR, Becktel JM, Singleton JW et al. Development of a Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterology 1976; 70: 439-44.
11. Henry WL, DeMaria A, Gramiak R et al. Report of the American Society of Echocardiography Committee on nomenclature and standards in two-dimensional echocardiography. Circulation 1980; 62: 212-17.
12. Freed LA, Levy D, Levine RA et al. Prevalence and clinical outcome of mitral-valve prolapse. N. Engl. J. Med. 1999; 341: 1-7.
13. Marks AR, Choong CY, Sanfilippo AJ et al. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N. Engl. J. Med. 1989; 320: 1031-6.
14. Louie EK, Langholz D, Mackin WJ et al. Transesophageal echocardiographic assessment of the contribution of intrinsic tissue thickness to the appearance of a thick mitral valve in patients with mitral valve prolapse. J. Am. Coll. Cardiol. 1996; 28: 465-71.
15. Chandraratna PAN, Nimalasuriya A, Kawanishi D et al. Identification of the increased frequency of cardiovascular abnormalities associated with mitral valve prolapse by two-dimensional echocardiography. Am. J. Cardiol. 1984; 54: 1283-5.
16. Weissman NJ, Pini R, Roman MJ et al. In vivo mitral valve morphology and motion in mitral valve prolapse. Am. J. Cardiol. 1994; 73: 1080-88.
17. Shah PM. Echocardiographic diagnosis of mitral valve prolapse. J. Am. Soc. Echocardiogr. 1994; 7: 286-93.
18. Qinones MA, Otto MC, Stoddard M et al. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J. Am. Soc. Echocardiogr. 2002; 15: 167-84.
19. Zoghbi WA, Enriquez-Sarano M, Foster E et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J. Am. Soc. Echocardiogr. 2003; 16: 777-802.
20. Helmcke F, Nanda NC, Hsiung MC et al. Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 1987; 75: 175-83.
21. Perry GJ, Helmcke F, Nanda NC et al. Evaluation of aortic insufficiency by Doppler color flow mapping. J. Am. Coll. Cardiol. 1987; 9: 952-9.
22. Reynolds T, Abate J, Tenney A et al. The JH/LVOH method in the quantification of aortic regurgitation: how the cardiac sonographer may avoid an important pitfall. J. Am. Soc. Echocardiogr. 1991; 4: 105-8.
23. Taylor R. Evolution of the continuity equation in the Doppler echocardiographic assesment of the severity of valvular aortic stenosis. J. Am. Soc. Echocardiogr. 1990; 3: 326-30.
24. Eisenberg MJ, Oken K, Guerrero S et al. Prognostic value of echocardiography in hospitalized patients with pericardial effusion. Am. J. Cardiol. 1992; 70: 934-9.
25. ten Cate FJ, Kloster FE, VanDorp WG et al. Dimensions and volumes of left atrium and ventricle determinated by single beam echocardiography. Br. Heart J. 1974; 36: 737-46.
26. Yock PG, Popp RL. Non-invasive estimation of right systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70: 657-62.
27. Teichholz LE, Kreulen T, Herman MV et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am. J. Cardiol. 1976; 37: 7-11.
28. Shiller NB, Shah PM, Crawford M et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J. Am. Soc. Echocardiogr. 1989; 2: 358-67.
29. Spirito P, Maron BJ. Doppler echocardiography for assessing left ventricular diastolic function. Ann. Intern. Med. 1988; 15: 122-6.
30. Weber P, Becker EW, Jenss H. Perikarderguss wahrend der Therapie eines Morbus Crohn mit 5-Aminosalicylsaure. Dtsch. Med. Wochenschr. 1988; 113: 1806-7.
31. Kupferschimdt H, Langenegger T, Krahenbuhl S. Perikarditis bei chronisch entzundlicher Darmerkrankung. Grundkrankheit oder Nebenwirkung der Therapie? Ein clinical problem. Schweiz. Med. Wochenschr. 1996; 126: 2184-90.
32. Castillo Dominguez JC, Anguita Sanchez M, Ramirez Moreno A et al. Aneurisma de la valva anterior mitral en un caso de endocarditis aortica en un paciente diagnosticado de colitis ulcerosa. Rev. Esp. Cardiol. 1998; 51: 604-6.
33. Kreuzpaintner G, Horstkotte D, Heyll A et al. Increased risk of bacterial endocarditis in inflammatory bowel disease. Am. J. Med. 1993; 94: 558-9.
34. Wackerlin A, Zund G, Maggiorini M et al. Aortenklappeninsuffizienz bei Morbus Crohn. Schweiz. Med. Wochenschr. 1997; 127: 935-9.
35. Reny JL, Paul JF, Lefebvre C et al. Association of Takayasu's arteritis and Crohn's disease. Result of a study on 44 Takayasu patients and review of literature. Ann. Med. Intern. 2003; 154: 85-90.
36. Reichardt P, Dahnert I, Tiller G et al. Possible activation of an intramyocardial inflammatoty process (Staphylococcus aureus) after treatment with infliximab in a boy with Crohn disease. Eur. J. Pediatr. 2002; 161: 281-3.
37. Weiss N, Rademacher A, Zoller WG et al. Myocarditis and subcutaneous granulomas in a patient with Crohn's disease of the colon. Am. J. Med. 1995; 99: 434-6.
38. Frid C, Bjarke B, Eriksson M. Myocarditis in children with inflammatory bowel disease. J. Pediatr. Gastroenterol. Nutr. 1986; 5: 964-5.
39. McKeon J, Haagsma B, Bett JH et al. Fatal giant cell myocarditis after colectomy for ulcerative colitis. Am. Heart J. 1986; 111: 1208-9.
40. Ariza A, Lopez MD, Mate JL et al. Giant cell myocarditis: monocytic immunophenotype of giant cells in a case associated with ulcerative colitis. Hum. Pathol. 1995; 26: 121-3.
41. Gonzalez Martin T, Dapena Vielba F, Ergueta Martin P et al. Acute pleuropericarditis and cardiac tamponade as extraintestinal complications of ulcerative colitis. Ann. Med. Intern. 1990; 7: 581-4.
42. Farley JD, Thomson AB, Dasgupta MK. Pericarditis and ulcerative colitis. J. Clin. Gastroenterol. 1986; 8: 567-8.
43. Manomohan V, Subbuswamy SG, Willoughby CP. Crohn's disease and pericarditis. Postgrad. Med. J. 1984; 60: 682-4.
44. Vayre F, Vayre-Oundjian L, Monsuez JJ. Pericarditis associated with longstanding mesalazine administration in a patient. Int. J. Cardiol. 1999; 68: 243-5.
45. Waite RA, Malinowski JM. Possible mesalamine-induced pericarditis: case report and literature review. Pharmacotherapy 2002; 22: 391-4.
46. Sentongo TA, Piccoli DA. Recurrent pericarditis due to mesalamine hypersensitivity: a pediatric case report and review of the literature. J. Pediatr. Gastroenterol. Nutr. 1998; 27: 344-7.
47. Gujral N, Friedenberg F, Friedenberg J et al. Pleuropericarditis related to the use of mesalamine. Dig. Dis. Sci. 1996; 41: 624-6.
48. Ishikawa N, Imamura T, Nakajima K et al. Acute pericarditis associated with 5-aminosalicylic acid (5-ASA) treatment for severe active ulcerative colitis. Intern. Med. 2001; 40: 901-4.
49. Adhiyaman V, Vaishnavi A, Froese S. Drug points: hypersensitivity reaction to balsalazide. BMJ 2001; 323: 489.
50. Kaiser GC, Milov DE, Erhart NA et al. Massive pericardial effusion in a child following the administration of mesalamine. J. Pediatr. Gastroenterol. Nutr. 1997; 25: 435-8.
51. Thompson DG, Lennard-Jones JE, Swarbrick ET et al. Pericarditis and inflammatory bowel disease. Q. J. Med. 1979; 48: 93-7.
52. Pent MT, Ganapathy S, Holdsworth CD et al. Mesalazine-induced lupus-like syndrome. BMJ 1992; 305: 159.
53. Griffiths ID, Kane SP. Sulphasalazine induced lupus syndrome in ulcerative colitis. BMJ 1977; 2: 1188-9.
54. Deboever G, Devogelaere R, Holvoet G. Sulphasalazine induced lupus like syndrome with cardiac tamponade in a patient with ulcerative colitis. Am. J. Gastroenterol. 1989; 84: 85-6.
55. Sander GE, Giles TD. Cardiovascular complications of collagen vascular disease. Curr. Treat. Options Cardiovasc. Med. 2002; 4: 151-9.
56. Guedes C, Bianchi-Fior P, Cormier B et al. Cardiac manifestations of rheumatoid arthritis: a case-control transesophageal echocardiography study in 30 patients. Arthritis Rheum. 2001; 45: 129-35.
57. Yildirir A, Aksoyek S, Calguneri M et al. Echocardiographic evidence of cardiac involvement in ankylosing spondylitis. Clin. Rheumatol. 2002; 21: 129-34.
58. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205.
59. Cesari M, Penninx BW, Newman AB et al. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). Am. J. Cardiol. 2003; 92: 522-8.
60. Guilherme L, Cunha-Neto E, Tanaka AC et al. Heart-directed autoimmunity: the case of rheumatic fever. J. Autoimmun. 2001; 16: 363-7.
61. Bradham WS, Bozkurt B, Gunasinghe H et al. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovasc. Res. 2002; 53: 822-30.
62. Banan A, Zhang Y, Losurdo J et al. Carbonylation and disassembly of the F-actin cytoskeleton in oxidant induced barrier dysfunction and its prevention by epidermal growth factor and trasforming growth factor alpha in a human colonic cell line. Gut 2000; 46: 830-37.
63. Kjeldsen J, Rasmussen M, Schaffalitzky de Muckadell OB et al. Collagen metabolites in the peripheral and splanchnic circulation of patients with Crohn's disease. Scand. J. Gastroenterol. 2001; 36: 1193-7.
64. Kjeldsen J, Schaffalitzky de Muckadell OB, Junker P. Seromarkers of collagen I and III metabolism in active Crohn's disease. Relation to disease activity and response to therapy. Gut 1995; 37: 805-10.